Malaria vaccines raise hopes as they reach critical trial phase of trumping the disease
A vaccine against malaria has shown promise in early clinical trials, raising hopes that it might one day prove to be an effective weapon against one of the world’s biggest killers of children. In a trial in 450 children aged 5-17 months, the vaccine, called R21, was up to 77...
